Escherichia coli lipopolisacharide (LPS) induced endotoxemia in horses: Effects of anti-inflammatory drugs on seric and peritoneal tumor necrosis factor alpha (TNF-α) concentrations;Endotoxemia por lipopolissacarídeo de Escherichia coli, em eqüinos: Efeitos de antiinflamatórios nas concentrações sérica e peritoneal do fator de necrose tumoral alfa (TNF-α)

Arquivo Brasileiro de Medicina Veterinaria e Zootecnia

Volumn 59, Issue 4, 2007, Pages 837-843

  Campebell, R C ^a   Peiro J R ^b   Rosa, P C S ^c   Valadao C A A ^b   Bechara, G H ^b  

^a UPIS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c Médica Veterinária Autônoma   (Brazil)

Author keywords

Cytocin; Dexamethazone; Endotoxin; Sodium diclofenac

Indexed keywords

ANIMALIA; EQUIDAE; ESCHERICHIA COLI;

EID: 35848949348     PISSN: 01020935     EISSN: 16784162     Source Type: Journal    
DOI: 10.1590/s0102-09352007000400003     Document Type: Article

References (37)

1. ALLEN, G.K.; CAMPBELL-BEGGS, C.; ROBISON, J.A. et al. Induction of early-phase endotoxin tolerance in horses. Equine Vet. J., v.28, p.269-274, 1996.
2. BARTON, M.H.; COLLATOS, C. Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J. Vet. Intern. Med., v.13, p.456-464, 1999.
3. BARTON, M.H.; COLLATOS, C.; MOORE, J.N. Endotoxin induced expression of tumor necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Equine Vet. J., v.28, p.382-389, 1996.
4. BARTON, M.H.; BRUCE, E.H.; MOORE, J.N. et al. Effects of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia. Am. J. Vet. Res., v.59, p.792-797, 1998.
5. BERTONE, A.L.; PALMER, J.L.; JONES, J. et al. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet. Surg., v.30, p.528-538, 2001.
6. BEYAERT, R.; FIERS, W. Tumor necrosis factor and lymphotoxin. In: MIRE-SLUIS, A., THORPE, R. (Eds). Citokines. California: Academic, 1998. p.335-360.
7. BUENO, A.C.; SEABORN, T.L.; CORNICK-SAEBORN, J. et al. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin. Am. J. Vet. Res., v.60, p.969-976, 1999.
8. BURROWS, G.E. Equine Escherichia coli endotoxemia: comparison of intravenous and intraperitoneal endotoxin administration. Am. J. Vet. Res., v.40, p.991-998, 1979.
9. CAMPEBELL, R.C.; PEIRÓ, J.R.; VALADÃO, C.A.A. et al. Effects of lidocaine on lipopolysaccharide-induced synovitis in horses. Arq. Bras. Med. Vet. Zootec. v.56, p.281-291, 2004.
10. CANNON, G.W. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib phase III protocol 035 study group. Arthritis Rheum., v.43, p.978-987, 2000.
11. CARGILE, J.L.; MAcKAY, R.J.; DANKER, J.R. et al. Effects of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic and circulating TNF responses of Miniature Horses given endotoxin. Am. J. Vet. Res., v.56, p.1451-1459, 1995.
12. CUNHA, F.Q.; SOUZA, G.E. P.; FERREIRA, S.H. The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. Eur. J. Pharm., v.129, p.65-76, 1986.
13. FACCIOLI, L.H.; SOUZA, G.E.; CUNHA, F.Q. et al. Recombinant interleuckin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions, v.30, p.344-349, 1990.
14. FLICK, D.A.; GIFFORD, G.E. Comparison of in vitro cell cytotoxic assay for TNF. J. Immunol. Methods, v.68, p.167, 1984.
15. HARKINS, J.D.; MacKAY, R.J.; MacKAY, S.L.D. et al. Clinical use and characteristics of the corticosteroids. Vet. Clin. N. Am.: Equine Pract., v.9, p.543-562, 1993.
16. HAWKINS, D.L.; CARNEY, J.M.; TOBIN, T. Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages. Vet. Immun. Immunop., v.66, p.1-10, 1998.
17. KING, J.N.; GERRING, E.L. The action of low dose endotoxin on equine bowel motility. Equine Vet. J., v.23, p.11-17, 1991.
18. KU, E.C.; LEE, W.; KOTHARI, H.V. et al. Effect of diclofenac sodium on the arachidonic acid cascade. Am. J. Med., v.80, suppl. 4B, p.18-23, 1986.
19. LOCHNER, F.K. The use of allopurinol in an endotoxin shock model in the horse. In: EQUINE COLIC RESEARCH SYMPOSIUM, Athens. Proceedings... Athens, 1986. p.39.
20. MAcKAY, R.J.; MERRIT, A.M.; ZERTUCHE, J.M. et al. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am. J. Vet. Res., v.52, p. 533-538, 1991.
21. MEAGER, A.; LEUNG, H.; WOOLLEY, J. Assays for tumour necrosis factor and related cytokines. J. Immun. Methods., v.116, p.1-17, 1989.
22. MOORE, J.N. Recognition and treatment of endotoxemia. Vet. Clin. N. Am.: Equine Pract., v.4, p.105-114, 1988.
23. MOORE, J.N. A perspective on endotoxemia. In: AMERICAN ASSOCIATION OF EQUINE PRACTITIONERS, 47., Albuquerque. Proceedings...Albuquerque, 2001. p.61-74.
24. MORRIS, D.D. Bacterial infections of the newborn foal. Part I: Clinical presentation, laboratory findings, and pathogenesis. Comp. Cont. Ed. Pract. Vet., v.6, p.A332-A341, 1984.
25. MORRIS, D.D.; MOORE, J.N.; CROWE, N. et al. Dexamethasone reduces endotoxin-induced tumor necrosis factor activity production in vitro by equine peritoneal macrophages. Cornell Vet., v.81, p.267-276, 1991.
26. OLSON, N.C.; HELLYER, P.W.; DODAM, J.R. Mediators and vascular effects in response to endotoxin. Br. Vet. J., v.151, p.489-522, 1995.
27. PARVIAINEN, A.K.; BARTON, M.H.; NORTON, N.N. Evaluation of polymyxin B in ex vivo model of endotoxemia in horses. Am. J. Vet. Res., v.62, p.72-76, 2001.
28. PEIRÓ, J.R. Aspectos clínico-laboratoriais e inflamatórios da injeção intraperitoneal de lipopolissacarídeo (LPS) em eqüinos: efeitos da lidocaí na. 2002. 74f. Tese (Doutorado) - Faculdade de Ciências Agrárias e Veterinárias, Universidade Estadual Paulista, Jaboticabal, SP.
29. PEIRÓ, J.R.; CAMPEBELL, R.C.; SANTANA, A.F. et al. Clinical and laboratory evaluation after intraperitoneal injection of lipopolysaccharide (LPS). J. Equine Vet. Sci., v.19, p.185-189, 1999.
30. ROCHA, N.P.; FERREIRA, S.H. Restoration by levamisole of endotoxin-inhibited neutrophil migration, oedema and increased vascular permeability induced by carrageenin. Eur. J. Pharmacol., v.122, p.87-92, 1986.
31. ROSA, P.C.; PEIRÓ, J.R.; CAMPEBELL, C.A.A. et al. Effects of diclofenac and dexamethasone on horse experimental endotoxemia. Arq. Bras. Med. Vet Zootec., v.55, p.279-286, 2003.
32. SCHOLER, D.W.; KU, E.C.; BOETTCHER, I. et al. Pharmacology of diclofenac sodium. Am. J. Med., v.80, suppl 4B, p.34-38, 1986.
33. SCHWARTZ, J.I.; CHAN, C.C.; MUKHOPADHYAN, S. et al. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin. Pharmacol., v.65, p.653-660, 1999.
34. SOUZA, G.E. P.; FERREIRA, S.H. Blockage by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents Actions, v.17, p.97-103, 1985.
35. VALADÃO, C.A.A.; PEIRÓ, J.R.; SANTANA, A.E. et al. Evaluation of peritoneal fluid in horses with experimental endotoxemia. J. Equine Vet. Sci., v.15, p.124-128, 1995.
36. WAGNER, A.E.; COLLIN, I.D.; WERTZ, E.M. et al. Hemodynamic responses of horses to anesthesia and surgery, before and after administration of a low dose of endotoxin. Vet. Surg., v.24, p.78-85, 1995.
37. WARD, D.S.; FESSLER, J.F.; BOTTOMS, G.D. et al. Equine endotoxemia: cardiovascular, eicosanoid, hematologic, blood cervical, and plasma enzyme alterations. Am. J. Vet. Res., v.48, p.1150-1156, 1987.